Conleth

Frustrating to see discussion (and/or tacit endorsement) of treatments unsupported by evidence at #ASCO24 . At the endometrial cancer session 40% of the audience voted to give trastuzumab deruxtecan to a patient with HER2 2+ IHC. This should be called out more strongly!

Really looking forward to this event organised by @UCCCancerTrials this coming Friday. The afternoon session is free to the public. Get to know the Cancer Research team and take part in some fun workshops. Can’t wait! Register at eventbrite.ie/e/art4knowledg….

Moonlit night ⁦@UCC⁩, what a campus!

I did not know that (A) squirrels were speeders (B) squirrels could read. Every day is a school day…

Congrats ⁦@aduffy74⁩, great article about a great writer. Austin Duffy: ‘I wanted to immerse the reader in the terror of being on call’ theguardian.com/books/2022/jul…